Skip to main content
. 2024 Nov 11;19(11):e0312851. doi: 10.1371/journal.pone.0312851

Fig 8. The common change of proteins after MDA-MB-231 was exposed to CB agonists was investigated.

Fig 8

(A) The dot plot presented the level of ALDOC protein as log2 fold change normalized to control after 48 hours of treatment. (B) Overall survival analysis of ALDOC protein in triple-negative breast cancer (TNBC) (n = 67 in both groups). (C) Meta-analysis of ALDOC expression between normal tissues and breast cancer tissues. (*p < 0.05, ****p<0.0001).